ACM-1

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameACM-1
Drug Alias NameACM-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsNeovascularization, Pathologic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSun Yat-Sen University
Active IndicationsN/A
Inactive IndicationsNeovascularization, Pathologic

Other Information

ATC CodeN/A
Related LinksN/A